|
Oct 17
|
With 50% ownership, OPKO Health, Inc. (NASDAQ:OPK) insiders have a lot riding on the company's future
|
|
Oct 11
|
OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies
|
|
Jan 11
|
Shockwave Medical (SWAV) Surges 7.8%: Is This an Indication of Further Gains?
|
|
Jan 9
|
OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes
|
|
Dec 7
|
Here's Why You Should Retain OPKO Health (OPK) Stock for Now
|
|
Dec 6
|
Why Is OPKO Health (OPK) Up 18.7% Since Last Earnings Report?
|
|
Nov 28
|
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
|
|
Nov 7
|
Q3 2023 OPKO Health Inc Earnings Call
|
|
Nov 7
|
OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues Top
|
|
Nov 7
|
OPKO Health, Inc. (NASDAQ:OPK) Q3 2023 Earnings Call Transcript
|
|
Nov 7
|
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
|
|
Nov 7
|
Opko Health (OPK) Q3 2023 Earnings Call Transcript
|
|
Nov 7
|
OPKO Health (OPK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Sep 29
|
OPKO Health Inc (OPK): A Deep Dive into Its Performance Potential
|
|
Sep 28
|
OPKO Health (OPK) - A Fairly Valued Stock with Room for Growth?
|
|
Sep 28
|
ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats
|